fluorobenzenes has been researched along with HIV Coinfection in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (32.00) | 29.6817 |
| 2010's | 15 (60.00) | 24.3611 |
| 2020's | 2 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves Saldanha, S; Battegay, M; Cavassini, M; Courlet, P; Decosterd, LA; Livio, F; Marzolini, C; Scherrer, A; Stoeckle, M | 1 |
| Alves Saldanha, S; Buclin, T; Cavassini, M; Courlet, P; Csajka, C; Decosterd, LA; Guidi, M; Marzolini, C; Stader, F; Stoeckle, M; Traytel, A | 1 |
| Clagett, B; Debanne, SM; Funderburg, NT; Jiang, Y; Labbato, D; Lederman, MM; McComsey, GA; Robinson, J; Storer, N | 1 |
| Debanne, SM; Eckard, AR; Funderburg, NT; Jiang, Y; McComsey, GA | 1 |
| Dubé, MP | 1 |
| Funderburg, NT; Hileman, CO; Longenecker, CT; McComsey, GA | 1 |
| Debanne, SM; Erlandson, KM; Jiang, Y; McComsey, GA | 1 |
| Clagett, B; Debanne, SM; Ferrari, B; Funderburg, NT; Jiang, Y; Juchnowski, S; Labbato, D; Lederman, MM; McComsey, GA; Robinson, J | 1 |
| Debanne, S; Dirajlal-Fargo, S; Hileman, CO; Jiang, Y; Kinley, B; Longenecker, CT; McComsey, GA | 1 |
| Bain, AM; Busti, AJ; Rahman, AP; Rutherford, WS; White, EA | 1 |
| Calza, L; Chiodo, F; Colangeli, V; Manfredi, R; Pavoni, M; Pocaterra, D | 1 |
| Boffito, M; Collot-Teixeira, S; De Lorenzo, F; Gazzard, B; McGregor, JL; Shotliff, K; Xiao, H | 1 |
| Calza, L; Falasca, K; Mancino, P; Pizzigallo, E; Ucciferri, C; Vecchiet, J | 1 |
| Aslangul, E; Assoumou, L; Bittar, R; Boccara, F; Bonnefont-Rousselot, D; Costagliola, D; Fiévet, MH; Giral, P; Kalmykova, O; Melchior, JC; Peytavin, G; Valantin, MA | 1 |
| Crane, HM; Crane, PK; Harrington, RD; Kitahata, MM; Knopp, RH; Kosel, BW; Mugavero, MJ; Saag, MS; Singh, S; Willig, JH | 1 |
| Bárcena, R; Fortún, J; Graus, J; Moreno, A; Moreno, S; Nuño, J; Pérez-Elías, MJ; Quereda, C; Rodriguez-Gandía, MA; Wikman, P | 1 |
| Citkowitz, E | 1 |
| Burger, DM; de Kanter, CT; Keuter, M; Koopmans, PP; van der Lee, MJ | 1 |
| Colotto, M; Durante, C; Renzi, A | 1 |
| Calza, L; Colangeli, V; Danese, I; Magistrelli, E; Manfredi, R; Salvadori, C; Serra, C; Trapani, FF; Verucchi, G; Viale, P | 1 |
| Cunha, RV; Domingos, H; Domingos, JA; Paniago, AM; Rodrigues, RL; Souza, AS | 1 |
| Calza, L; Chiodo, F; Colangeli, V; Legnani, G; Manfredi, R; Pocaterra, D; Tampellini, L | 1 |
| Bennett, MT; Bondy, GP; Johns, KW | 2 |
| Bäumer, A; Burger, D; de Groot, E; Fätkenheuer, G; Koopmans, P; Kroon, F; Reiss, P; Rockstroh, J; Sankatsing, R; Schippers, E; Stroes, E; van der Lee, M; van der Ven, A; Vogel, M; Wyen, C | 1 |
1 review(s) available for fluorobenzenes and HIV Coinfection
| Article | Year |
|---|---|
A multimodal, evidence-based approach to achieve lipid targets in the treatment of antiretroviral-associated dyslipidemia: case report and review of the literature.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dyslipidemias; Fluorobenzenes; HIV Infections; Humans; Hypolipidemic Agents; Male; Middle Aged; Nevirapine; Patient Compliance; Pyrimidines; Reverse Transcriptase Inhibitors; Rosuvastatin Calcium; Sulfonamides | 2008 |
10 trial(s) available for fluorobenzenes and HIV Coinfection
| Article | Year |
|---|---|
Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.
Topics: Adult; Anti-Inflammatory Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Female; Fluorobenzenes; HIV Infections; Humans; Male; Middle Aged; Monocytes; Placebos; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2014 |
Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Anti-Retroviral Agents; Biomarkers; Cardiovascular Diseases; Cholesterol, LDL; Double-Blind Method; Female; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prospective Studies; Pyrimidines; Regression Analysis; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Vasculitis | 2014 |
Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial.
Topics: Adult; AIDS-Associated Nephropathy; Anti-Retroviral Agents; Biomarkers; Cystatin C; Female; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Kidney; Kidney Function Tests; Male; Middle Aged; Placebos; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2014 |
Effects of randomized rosuvastatin compared with placebo on bone and body composition among HIV-infected adults.
Topics: Absorptiometry, Photon; Adult; Biomarkers; Body Composition; Bone Density; Cardiovascular Diseases; Female; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Male; Middle Aged; Osteoporosis; Pyrimidines; Receptors, Tumor Necrosis Factor, Type I; Regression Analysis; Risk Factors; Rosuvastatin Calcium; Sulfonamides | 2015 |
Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy.
Topics: Adult; Anti-Retroviral Agents; Anticholesteremic Agents; Antigens, CD; Female; Fluorobenzenes; HIV Infections; HLA-DR Antigens; Humans; Male; Middle Aged; Monocytes; Programmed Cell Death 1 Receptor; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; T-Lymphocytes; Treatment Outcome; Vasculitis | 2015 |
Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: randomized placebo-controlled trial.
Topics: Adult; Anti-Retroviral Agents; Anticholesteremic Agents; Cardiovascular Diseases; Enzyme-Linked Immunosorbent Assay; Female; Fluorobenzenes; HIV Infections; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Placebos; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2015 |
Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesterolaemia in HIV-infected patients receiving protease inhibitors.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Cholesterol; Female; Fluorobenzenes; Follow-Up Studies; Heptanoic Acids; HIV Infections; HIV Protease Inhibitors; Humans; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Prospective Studies; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Viral Load | 2008 |
Prevention of atherosclerosis in patients living with HIV.
Topics: Administration, Oral; Adult; Antiretroviral Therapy, Highly Active; Atherosclerosis; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Disease Progression; Double-Blind Method; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Middle Aged; Pyrimidines; Research Design; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome | 2009 |
Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial.
Topics: Adult; Anticholesteremic Agents; Cholesterol, LDL; Dyslipidemias; Female; Fluorobenzenes; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Pravastatin; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Viral Load | 2010 |
Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.
Topics: Adolescent; Adult; Aged; Antiretroviral Therapy, Highly Active; Atherosclerosis; Carotid Intima-Media Thickness; Cholesterol; Female; Fluorobenzenes; Follow-Up Studies; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Triglycerides; Young Adult | 2013 |
14 other study(ies) available for fluorobenzenes and HIV Coinfection
| Article | Year |
|---|---|
Real-life management of drug-drug interactions between antiretrovirals and statins.
Topics: Cohort Studies; Drug Interactions; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pharmaceutical Preparations; Pyrroles | 2020 |
Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV.
Topics: Anti-Retroviral Agents; Cholesterol; Cholesterol, HDL; Female; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Rosuvastatin Calcium | 2021 |
Will statins be an effective anti-inflammatory intervention for prevention of cardiovascular disease in patients with HIV?
Topics: Anti-Retroviral Agents; Cardiovascular Diseases; Female; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Vasculitis | 2014 |
Severe HIV-associated hypertriglyceridaemia treated with rosuvastatin plus omega-3 fatty acids.
Topics: Adult; Drug Therapy, Combination; Fatty Acids, Omega-3; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2009 |
Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.
Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Cholesterol; Cohort Studies; Dyslipidemias; Female; Fluorobenzenes; Heptanoic Acids; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrimidines; Pyrroles; Retrospective Studies; Rosuvastatin Calcium; Serum; Sulfonamides | 2011 |
Severe rhabdomyolysis due to rosuvastatin in a liver transplant subject with human immunodeficiency virus and immunosuppressive therapy-related dyslipidemia.
Topics: Adult; Antiretroviral Therapy, Highly Active; Dyslipidemias; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Liver Transplantation; Male; Pyrimidines; Rhabdomyolysis; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides | 2011 |
Was the low-density lipoprotein cholesterol level really elevated?
Topics: Dyslipidemias; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Liver Transplantation; Male; Pyrimidines; Rhabdomyolysis; Sulfonamides | 2011 |
Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavir.
Topics: Anti-HIV Agents; Drug Therapy, Combination; Dyslipidemias; Fluorobenzenes; HIV Infections; HIV-1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lopinavir; Male; Middle Aged; Pyrimidines; Pyrimidinones; Renal Insufficiency; Rhabdomyolysis; Ritonavir; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2011 |
Into the wardrobe of Narnia: beyond HIV infection a world of cardiovascular risk.
Topics: Acromegaly; Adenoma; Adult; Azetidines; Cardiovascular Diseases; Coinfection; Ezetimibe; Female; Fluorobenzenes; Hepatitis C; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Magnetic Resonance Imaging; Pituitary Neoplasms; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Sulfonamides | 2012 |
Rosuvastatin and ciprofibrate in the treatment of dyslipidemia in patients with HIV.
Topics: Adult; Antiretroviral Therapy, Highly Active; Cardiovascular Diseases; Cholesterol; Dyslipidemias; Female; Fibric Acids; Fluorobenzenes; HIV Infections; Humans; Hypolipidemic Agents; Male; Middle Aged; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Statistics, Nonparametric; Sulfonamides; Treatment Outcome; Triglycerides | 2012 |
Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot study.
Topics: Adult; Antiretroviral Therapy, Highly Active; Cholesterol; Female; Fluorobenzenes; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Pilot Projects; Prospective Studies; Pyrimidines; Reverse Transcriptase Inhibitors; Rosuvastatin Calcium; Sulfonamides; Triglycerides | 2005 |
Ezetimibe is effective when added to maximally tolerated lipid lowering therapy in patients with HIV.
Topics: Adult; Aged; Anti-Retroviral Agents; Anticholesteremic Agents; Apolipoprotein B-100; Atorvastatin; Azetidines; Cholesterol; Ezetimibe; Female; Fluorobenzenes; Heptanoic Acids; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Protease Inhibitors; Pyrimidines; Pyrroles; Retrospective Studies; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Triglycerides | 2007 |
Are HIV positive patients resistant to statin therapy?
Topics: Cholesterol; Drug Resistance, Multiple, Viral; Dyslipidemias; Female; Fluorobenzenes; HIV Infections; HIV Seropositivity; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrimidines; Retrospective Studies; Rosuvastatin Calcium; Sulfonamides | 2007 |
Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Drug Therapy, Combination; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lopinavir; Middle Aged; Pilot Projects; Pyrimidines; Pyrimidinones; Ritonavir; Rosuvastatin Calcium; Sulfonamides | 2007 |